← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

Chief Commercial Officer John Demaree bought $109K of Karyopharm Therapeutics Inc.

Bought$109,013
$14.54Price
7,500Shares

What KPTI did for a copier

Prices for KPTI after this filing aren't in yet.

John Demaree's record

1 other buy on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Wed, Aug 26. Filed Thu, Aug 27, 12:00 PM ET, during the session. Not investment advice.